RTI Surgical Celebrates First Human Implantation of map3 Cellular Allogeneic Bone Graft
8/12/2013 9:55:15 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, is pleased to announce that the first human implantation of the company’s map3™ Cellular Allogeneic Bone Graft implant was completed last week.
Help employers find you! Check out all the jobs and post your resume.
comments powered by